Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07221903

The Lateral, Anterior, Medial (LAM) Femoral Cutaneous Block: A Case Series Harborview Medical Center, Seattle, WA

Status
Recruiting
Phase
Study type
Observational
Enrollment
10 (estimated)
Sponsor
University of Washington · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Skin donor sites in patients undergoing split-thickness skin grafting surgeries can be very painful postoperatively. This site is most often the anterolateral thigh, the pain at which location can traditionally be covered by a fascia iliaca nerve block, although that comes with the disadvantage of losing motor functions in the femoral nerve distribution. The LAM nerve block, which is relatively new, aims to provide analgesia in the distribution of the lateral and anterior femoral cutaneous nerves. In short, this nerve block would decrease the sensation of the anterolateral thigh area without affecting the motor function of the leg. Investigators aim to study the consistency and coverage size of sensation changes by mapping out the area after the block in each patient.

Conditions

Timeline

Start date
2025-10-22
Primary completion
2026-12-31
Completion
2026-12-31
First posted
2025-10-28
Last updated
2025-11-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT07221903. Inclusion in this directory is not an endorsement.

The Lateral, Anterior, Medial (LAM) Femoral Cutaneous Block: A Case Series Harborview Medical Center, Seattle, WA (NCT07221903) · Clinical Trials Directory